RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
PIGA A
Collezione AOU San Luigi di Orbassano
Items : 26
Overall and complication-free survival in a large cohort of patients with ?-thalassemia major followed over 50?years. in American journal of hematology / Am J Hematol. 2023 Mar;98(3):381-387. doi: 10.1002/ajh.26798. Epub 2023 Jan 1.
2023
AOU San Luigi di Orbassano
Forni GL; Gianesin B; Musallam KM; Longo F; Rosso R; Lisi R; Gamberini MR; Pinto VM; Graziadei G; Vitucci A; Bonetti F; Musto P; Piga A; Cappellini MD; Borgna-Pignatti C;
Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from three decades of follow-up in a high-income setting. in Haematologica / Haematologica. 2023 Apr 1;108(4):1158-1162. doi: 10.3324/haematol.2022.280815.
2023
AOU San Luigi di Orbassano
Pinto VM; Gianesin B; Piel FB; Longo F; Rigano P; Quota A; Spadola V; Graziadei G; Mazzi F; Cappellini MD; Maggio A; Piga A; De Franceschi L; Forni GL;
Mortality in ?-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization. in Blood / Blood. 2022 Mar 31;139(13):2080-2083. doi: 10.1182/blood.2021014862.
2022
AOU San Luigi di Orbassano
Pinto VM; Musallam KM; Derchi G; Graziadei G; Giuditta M; Origa R; Barella S; Casu G; Pasanisi A; Longo F; Casale M; Miceli R; Merella P; Tartaglione I; Piga A; Cappellini MD; Gianesin B; Forni GL;
Tricuspid-valve regurgitant jet velocity as a risk factor for death in ?-thalassemia. in Haematologica / Haematologica. 2022 Jul 1;107(7):1714-1718. doi: 10.3324/haematol.2021.280389.
2022
AOU San Luigi di Orbassano
Derchi G; Musallam KM; Pinto VM; Graziadei G; Giuditta M; Barella S; Origa R; Casu G; Pasanisi A; Longo F; Casale M; Miceli R; Merella P; Gianesin B; Ameri P; Tartaglione I; Perrotta S; Piga A; Cappellini MD; Forni GL;
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection. in American journal of hematology / Am J Hematol. 2022 Feb 1;97(2):E75-E78. doi: 10.1002/ajh.26429. Epub 2021 Dec 10.
2022
AOU San Luigi di Orbassano
Denotti AR; Fortini M; Borsellino Z; Quintino S; Balocco M; Ricchi P; De Giovanni A; Graziadei G; Migone De Amicis M; Gaglioti C; Serra M; Putti MC; Carrai V; Gentile M; Bagnato S; Miano M; Lisi R; De Michele E; Massa A; Campisi S; Arcioni F; Quota A; Ribersani M; Quaresima M; Pitrolo L; Bonetti F; Vitucci A; Dal Zotto C; Roberti D; et alii...
Long-Term Effects of Iron Chelating Agents on Ocular Function in Patients with Thalassemia Major. in Clinical ophthalmology (Auckland, N.Z.) / Clin Ophthalmol. 2021 May 20;15:2099-2109. doi: 10.2147/OPTH.S300974. eCollection 2021.
2021
AOU San Luigi di Orbassano
Nuzzi R; Geronazzo G; Tridico F; Nuzzi A; Caselgrandi P; Piga AG;
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients. in The pharmacogenomics journal / Pharmacogenomics J. 2019 Oct;19(5):417-427. doi: 10.1038/s41397-019-0071-7. Epub 2019 Jan 17.
2019
ASL Città di Torino
AOU San Luigi di Orbassano
Piga A; De Nicolò A; Avataneo V; Massano D; Pirro E; Longo F; De Francia S; Cusato J; Allegra S; D'Avolio A;
Prevalence and prognostic impact of left ventricular non-compaction in patients with thalassemia. in Internal and emergency medicine / Intern Emerg Med. 2019 Nov;14(8):1299-1306. doi: 10.1007/s11739-019-02114-3. Epub 2019 Jun 25.
2019
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
ASL Biella
Longo F; Limone M; Gatti M; Xhyheri B; Faletti R; Imazio M; Piga A; Bonamini R;
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience. in Orphanet journal of rare diseases / Orphanet J Rare Dis. 2019 May 30;14(1):120. doi: 10.1186/s13023-019-1099-0.
2019
AOU San Luigi di Orbassano
Russo G; De Franceschi L; Colombatti R; Rigano P; Perrotta S; Voi V; Palazzi G; Fidone C; Quota A; Graziadei G; Pietrangelo A; Pinto V; Ruffo GB; Sorrentino F; Venturelli D; Casale M; Ferrara F; Sainati L; Cappellini MD; Piga A; Maggio A; Forni GL;
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2018 Sep;28(9):199-206. doi: 10.1097/FPC.0000000000000348.
2018
ASL Città di Torino
AOU San Luigi di Orbassano
Piga A; De Nicolò A; Avataneo V; Pirro E; Massano D; De Francia S; Longo F; Cusato J; Allegra S; D'Avolio A;
Dual-Energy X-ray Absorptiometry Predictors of Vertebral Deformities in Beta-Thalassemia Major. in Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry / J Clin Densitom. 2018 Oct-Dec;21(4):507-516. doi: 10.1016/j.jocd.2017.06.028. Epub 2017 Jul 27.
2018
AOU San Luigi di Orbassano
Osella G; Priola AM; Priola SM; Piga A; Longo F; Ventura M; Bentivegna G; Angeli A; Veltri A; Terzolo M; Osella G; Priola AM; Priola SM; Piga A; Longo F; Ventura M; Bentivegna G; Angeli A; Veltri A; Terzolo M;
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes. in The pharmacogenomics journal / Pharmacogenomics J. 2018 May 22;18(3):506-515. doi: 10.1038/tpj.2017.43. Epub 2017 Nov 21.
2018
ASL Città di Torino
AOU San Luigi di Orbassano
Piga A; De Nicolò A; Massano D; Pirro E; Longo F; Arduino A; De Francia S; Cusato J; Allegra S; D'Avolio A; Allegra S; Cusato J; De Francia S; Arduino A; Longo F; Pirro E; Massano D; De Nicolò A; Piga A; D'Avolio A;
Clinical relevance of deferasirox trough levels in ?-thalassemia patients. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2018 Feb;45(2):213-216. doi: 10.1111/1440-1681.12879. Epub 2017 Dec 4.
2018
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; Cusato J; Pirro E; Piccione F; Longo F; De Francia S; Massano D; Allegra S; Piga A; Allegra S; Massano D; De Francia S; Longo F; Piccione F; Pirro E; Cusato J; D'Avolio A; Piga A;
Deferasirox pharmacokinetic evaluation in ?-thalassaemia paediatric patients. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 May;69(5):525-528. doi: 10.1111/jphp.12559. Epub 2016 May 27.
2017
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; Piga A; Massano D; Pirro E; De Francia S; Cusato J; Allegra S;
Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients. in Pharmacogenomics / Pharmacogenomics. 2017 Apr;18(6):539-554. doi: 10.2217/pgs-2016-0176. Epub 2017 Mar 27.
2017
ASL Città di Torino
AOU San Luigi di Orbassano
Piga A; Longo F; Massano D; Arduino A; Cusato J; De Francia S; Allegra S; D'Avolio A;
Deferasirox AUC efficacy cutoff and role of pharmacogenetics. in European journal of clinical pharmacology / Eur J Clin Pharmacol. 2016 Sep;72(9):1155-7. doi: 10.1007/s00228-016-2070-9. Epub 2016 May 18.
2016
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; Massano D; Piga A; De Francia S; Cusato J; Allegra S;
Deferasirox pharmacokinetic and toxicity correlation in ?-thalassaemia major treatment. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2016 Nov;68(11):1417-1421. doi: 10.1111/jphp.12638. Epub 2016 Sep 27.
2016
ASL Città di Torino
AOU San Luigi di Orbassano
Piga A; Massano D; Pirro E; Cusato J; De Francia S; Allegra S; D'Avolio A;
Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous ?-thalassaemia. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2016 Dec;84:1510-1512. doi: 10.1016/j.biopha.2016.11.041. Epub 2016 Nov 20.
2016
ASL Città di Torino
AOU San Luigi di Orbassano
Piga A; Pirro E; Arduino A; Cusato J; Massano D; Longo F; De Francia S; Allegra S; D'Avolio A;
Role of pharmacogenetics on deferasirox AUC and efficacy. in Pharmacogenomics / Pharmacogenomics. 2016 Apr;17(6):561-72. doi: 10.2217/pgs-2015-0001. Epub 2016 Apr 4.
2016
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; Piga A; Massano D; De Francia S; Allegra S; Cusato J;
Management of pulmonary arterial hypertension associated to thalassemia: when pulmonary endarterectomy is the best therapeutical option? A case report. in Journal of thrombosis and thrombolysis / J Thromb Thrombolysis. 2015 Jan;39(1):139-43. doi: 10.1007/s11239-014-1073-6.
2015
AOU San Luigi di Orbassano
Roggero S; Vullo S; Volpe G; Piga A; Albera C;
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study. in Pediatric blood & cancer / Pediatr Blood Cancer. 2015 Aug;62(8):1427-36. doi: 10.1002/pbc.25502. Epub 2015 Mar 23.
2015
AOU San Luigi di Orbassano
De Montalembert M; Abboud MR; Fiquet A; Inati A; Lebensburger JD; Kaddah N; Mokhtar G; Piga A; Halasa N; Inusa B; Rees DC; Heath PT; Telfer P; Driscoll C; Al Hajjar S; Tozzi A; Jiang Q; Emini EA; Gruber WC; Gurtman A; Scott DA;
Complete recovery from paraparesis in spinal cord compression due to extramedullary haemopoiesis in beta-thalassaemia by emergency radiation therapy. in Internal medicine journal / Intern Med J. 2014 Apr;44(4):409-12. doi: 10.1111/imj.12386.
2014
AOU San Luigi di Orbassano
Ruo Redda MG; Allis S; Reali A; Bartoncini S; Roggero S; Anglesio SM; Piga A;
A new HPLC UV validated method for therapeutic monitoring of deferasirox in thalassaemic patients. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Apr 15;893-894:127-33. doi: 10.1016/j.jchromb.20
2012
AOU San Luigi di Orbassano
De Francia S; Massano D; Piccione FM; Pirro E; Racca S; Di Carlo F; Piga A;
Exercise Stress Echocardiography with Tissue Doppler Imaging (TDI) Detects Early Systolic Dysfunction in Beta-Thalassemia Major Patients without Cardiac Iron Overload. in Mediterranean journal of hematology and infectious diseases / Mediterr J Hematol Infect Dis. 2012;4(1):e2012037. doi: 10.4084/MJHID.2012.037. Epub 2012 Jun 14.
2012
AOU San Luigi di Orbassano
Barbero U; Destefanis P; Pozzi R; Longo F; Piga A;
Diagnosis of juvenile hemochromatosis in an 11-year-old child combining genetic analysis and non-invasive liver iron quantitation. in European journal of pediatrics / Eur J Pediatr. 2003 Feb;162(2):96-9. doi: 10.1007/s00431-002-1114-6. Epub 2002 Dec 10.
2003
AOU San Luigi di Orbassano
De Gobbi M; Caruso R; Daraio F; Chianale F; Pinto RM; Longo F; Piga A; Camaschella C;
New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. in Blood / Blood. 2001 May 1;97(9):2555-60. doi: 10.1182/blood.v97.9.2555.
2001
AOU San Luigi di Orbassano
Roetto A; Totaro A; Piperno A; Piga A; Longo F; Garozzo G; Calì A; De Gobbi M; Gasparini P; Camaschella C;